Publicaciones

Publicaciones de los últimos siete años:

• Rincón E, Cejalvo T, Kanojia D, Alfranca A, Rodríguez-Milla MÁ, Hoyos RAG, Han Y, Zhang L, Alemany R, Lesniak MS, García-Castro J. Mesenchymal stem cell carriers enhance antitumor efficacy of oncolytic adenoviruses in an immunocompetent mouse model. Oncotarget. 2017. 8 (28):45415-45431. (A). (A). IF: 6,35.
• Moreno R, Rojas LA, Villellas FV, Soriano VC, García-Castro J, Fajardo CA, Alemany R. Human Menstrual Blood-Derived Mesenchymal Stem Cells as Potential Cell Carriers for Oncolytic Adenovirus. Stem Cells Int. 2017; 3615729. (A). IF: 3,54.
• Macia A, Widmann TJ, Heras S1, Ayllon V, Sanchez L, Benkaddour-Boumzaouad M, Munoz-Lopez M, Rubio A, Amador-Cubero S, Blanco-Jimenez E, Garcia-Castro J, Menendez P, Ng P, Muotri AR, Goodier JL, Garcia-Perez JL. Engineered LINE-1 retrotransposition in non-dividing human neurons. Genome Res. 2017, 27(3):335-348. (A). IF: 11,35.
• Almazán-Moga A, Zarzosa P, Vidal I, Molist C, Giralt I, Navarro N, Soriano A, Segura MF, Alfranca A, Garcia-Castro J, Sánchez de Toledo J, Roma J, Gallego S. Hedgehog Pathway Inhibition Hampers Sphere and Holoclone Formation in Rhabdomyosarcoma. Stem Cells Int. 2017. 7507380. (A). IF: 3,54.
• Toraño EG, Bayón GF, Del Real Á, Sierra MI, García MG, Carella A, Belmonte T, Urdinguio RG, Cubillo I, García-Castro J, Delgado-Calle J, Pérez-Campo FM, Riancho JA, Fraga MF, Fernández AF. Age-associated hydroxymethylation in human bone-marrow mesenchymal stem cells. J Transl Med. 2016, 14(1):207. (A). IF: 3,99.
• Abarrategi A, Tornin J, Martinez-Cruzado L, Hamilton A, Martinez-Campos E, Rodrigo JP, González MV, Baldini N, Garcia-Castro J, Rodriguez R. Osteosarcoma: Cells-of-Origin, Cancer Stem Cells, and Targeted Therapies. Stem Cells Int. 2016, 2016:3631764. (R). IF: 3,54.
• Martinez-Cruzado L, Tornin J, Santos L, Rodriguez A, García-Castro J, Morís F, Rodriguez R. Aldh1 Expression and Activity Increase During Tumor Evolution in Sarcoma Cancer Stem Cell Populations. Sci Rep. 2016, 6:27878. (A). IF: 5,228.
• Melen GJ, Franco L, Ruano D, González-Murillo Á, Alfranca A, Casco F, Lassaletta Á, Alonso M, Madero L, Alemany R, García-Castro J, Ramírez M. Influence of carrier cells on the clinical outcome of children with neuroblastoma treated with high dose of oncolytic adenovirus delivered in mesenchymal stem cells. Cancer letters 2016, 371, 2; 161-170. (A). IF: 5,62.
• Ramírez M, García-Castro J, Melen GJ, González-Murillo Á, Franco-Luzón L. Patient-derived mesenchymal stem cells as delivery vehicles for oncolytic virotherapy: novel state-of-the-art technology. Oncolytic Virother. 2015, Oct 14; 4:149-55. (R).
• Marina Martinez-Carmona, Alejandro Baeza, Miguel Angel Rodriguez-Milla, Javier García-Castro, Maria Vallet. Mesoporous silica nanoparticles grafted with light-responsive protein shell for highly cytotoxic antitumoral therapy. J. Mater. Chem. B 2015, 3: 5746-5752. (A). IF: 4,54
• Arantzazu Alfranca*, Lucia Martinez-Cruzado*, Juan Tornin*, Ander Abarrategi, Teresa Amaral, Enrique de Álava, Pablo Menéndez, Javier Garcia-Castro and Rene Rodriguez. Bone microenvironment signals in osteosarcoma development. Cellular and Molecular Life Sciences 2015, 72(16):3097-113. (R). IF: 5,85.
• Ana Entrena, Alberto Varas, Miriam Vázquez, Gustavo J Melen, Lidia M Fernández-Sevilla, Javier García-Castro, Manuel Ramírez, Agustín G. Zapata, Ángeles Vicente. Mesenchymal stem cells derived from low risk acute lymphoblastic leukemia patients promote NK cell antitumor activity. Cancer Letters 2015, 28; 363(2):156-65. (A). IF: 5,01.
• Agustín F. Fernandez, Gustavo F. Bayón, Rocío G. Urdinguio, Estela G. Toraño, Sandra Petrus, Cecilia Ferrero, Pablo Martinez-Camblor, Isabel Cubillo, Javier García-Castro, Jesús Delgado-Calle, José A. Riancho, Corrado Fagnani, Emanuela Medda, Virgilia Toccaceli, Sebastián Moran, Manel Esteller, Lorenza Nistico, María A. Stazi, Mario F. Fraga. H3K4me1 marks regions hypomethylated during aging in human stem and differentiated cells. Genome Research 2015, 25(1):27-40. (A). IF: 13,85.
• Cussó L, Mirones I, Peña-Zalbidea S, García-Vázquez V, García-Castro J, Desco M. Combination of Single-Photon Emission Computed Tomography and Magnetic Resonance Imaging to Track 111In-Oxine-Labeled Human Mesenchymal Stem Cells in Neuroblastoma-Bearing Mice. Molecular Imaging 2014, 13(10): 7290201400033. (A). IF: 2,19.
• Isabel Mirones, Miguel Ángel Rodríguez*, Isabel Cubillo, Luis Mariñas-Pardo, Teresa de la Cueva, Agustín Zapata, Carlos González, Manuel Ramírez, Javier García-Castro. Dopamine mobilizes mesenchymal progenitor cells into peripheral blood through D2-class receptors and their PI3K/AKT pathway. Stem Cells 2014, 32(9):2529-38. (A). IF: 7,74.
• Luis Antonio Mariñas-Pardo, Isabel Mirones-Aguilar, Oscar Amor-Carro, Rebeca Fraga-Iriso, Beatriz Lema-Costa, Isabel Cubillo-Moreno, Miguel Angel-Rodriguez Milla, Javier García-Castro*, David Ramos-Barbón*. Adipose-derived mesenchymal stem cells regulate airway contractile tissue remodeling in experimental asthma.  Allergy 2014, 69 (6):730-40. (A). IF: 5,88.
• R Rubio*, A Abarrategi*, J  Garcia-Castro*, L Martinez-Cruzado, C Suarez, J Tornin, L Santos, A Astudillo, I Colmenero, F Mulero, M Rosu-Myles, P Menendez, R Rodriguez. Bone environment is essential for osteosarcoma development from transformed mesenchymal stem cells. Stem Cells 2014, 32:1136–1148. (A). IF: 7,74.
• Á Vicente López, MN Vázquez García, GJ Melen, A Entrena Martínez, I Cubillo Moreno, J García-Castro, M Ramírez Orellana, AG Zapata González. Mesenchymal stromal cells derived from the bone marrow of acute lymphoblastic leukemia patients show altered BMP4 production: Correlations with the course of disease. Plos ONE 2014, 9(1):e84496. (A). IF: 4,41.
• Abarrategi A, Perez-Tavarez R, Rodriguez-Milla MA, Cubillo I, Mulero F, Alfranca A, Lopez-Lacomba JL, García-Castro J. In Vivo Ectopic Implantation Model to Assess Human Mesenchymal Progenitor Cell Potential. Stem Cell Rev. 2013, 9(6): 833-46. (A). IF: 4,52
• Isabel Mirones, Inmaculada de Prada, Ana M. Gómez, Alfonso Luque, Roberto Martín, M. Ángeles Pérez-Jiménez, Luis Madero, Javier García-Castro, Manuel Ramírez. A Role for the CXCR3/CXCL10 Axis in Rasmussen Encephalitis. Pediatric Neurology 2013, 49(6): 451-457. (A). IF: 1,40.
• Rodriguez-Milla MA, Mirones I, Mariñas-Pardo L, Melen GJ, Cubillo I, Ramírez M, García-Castro J. Enrichment of neural-related genes in human mesenchymal stem cells from neuroblastoma patients. Int J Mol Med. 2012, 30(2):365-73. (A). IF: 1,81.
• Abarrategi A, Marińas-Pardo L, Mirones I, Rincón E, García-Castro J. Mesenchymal niches of bone marrow in cancer. Clin Transl Oncol 2011, 13(9): 611-616. (R). IF: 1,25.
• Rodriguez R, Rubio R, Gutierrez-Aranda I, Melen GJ, Elosua C, García-Castro J, Menendez P. Fus-Chop Fusion Protein Expression Coupled to P53 Deficiency Induces Liposarcoma in Mouse but not Human Adipose-Derived Mesenchymal Stem/Stromal Cells. Stem Cells 2011, 29(2):179-92. (A). IF: 7,87.
• Ramírez M, García-Castro J, Alemany R. Oncolytic virotherapy for neuroblastoma. Discov Med. 2010, 10 (54):387-393. (R). IF: 3,42.
• I García-Gómez, G Elvira, AG Zapata, ML Lamana, M Ramírez, J García-Castro, M García Arranz, A Vicente, J Bueren, D García-Olmo. Mesenchymal stem cells: biological properties and clinical applications. Expert Opinion Biol Ther. 2010, 10(10):1453-68. (R). IF: 3,21.
• Garcia S, Martín MC, de la Fuente R, Cigudosa JC, Garcia-Castro J, Bernad A. Pitfalls in spontaneous in vitro transformation of human mesenchymal stem cells. Experimental Cell Research 2010, 316(9):1648-50. (A). IF: 3,94.
• García-Castro J, Alemany R, Cascalló M, Martínez-Quintanilla J, Del Mar Arriero M, Lassaletta A, Madero L, Ramírez M. Treatment of metastatic neuroblastoma with systemic oncolytic virotherapy delivered by autologous mesenchymal stem cells: an exploratory study. Cancer Gene Therapy. 2010, 17(7):476-83. (A). IF: 3,00.
• Ruth Rubio, Javier García-Castro, Iván Gutiérrez-Aranda, Jesús Paramio, Mirentxu Santos, Purificación Catalina, Paola Leone, Pablo Menendez, René Rodríguez. Deficiency in p53 but not retinoblastoma induces the transformation of mesenchymal stem cells in vitro and initiates leiomyosarcoma in vivo. Cancer Research  2010, 70 (10): 4185-94. (A). IF: 7,51.